Hemoglobinopathies mimicking Hb S/β-thalassemia: Hb S/S with α-thalassemia and Hb S/Volga

American Journal of Hematology

Volumn 81, Issue 5, 2006, Pages 361-365

  Loo, Hong Yuan ^a,b   Heeney, Matthew ^c   Wang, Winfred C ^d   Eung, Shawn H ^a,b   Ware, Russell E ^d   Steinberg, Martin H ^b   Chui, David H K ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

DNA diagnosis; Microcytosis; Sickle cell anemia; Unstable hemoglobin

Indexed keywords

GLOBIN; HEMOGLOBIN; HEMOGLOBIN C; HEMOGLOBIN E; HEMOGLOBIN S; UNCLASSIFIED DRUG;

ADOLESCENT; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; BLOOD TRANSFUSION; CASE REPORT; CHILD; COLUMN CHROMATOGRAPHY; DISEASE COURSE; ELECTROPHORESIS; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; HEMOGLOBIN VOLGA; HEMOGLOBINOPATHY; HETEROZYGOSITY; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ALPHA-THALASSEMIA; BETA-THALASSEMIA; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; GLOBINS; HEMOGLOBINS, ABNORMAL; HUMANS; MALE; SICKLE CELL TRAIT;

EID: 33646483677     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20562     Document Type: Article

References (26)

1. Steinberg MH, Embury SH. α-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. [Review]. Blood 1986;68:985-990.
2. Lorey F, Cunningham G, Vichinsky EP et al. Universal newborn screening for Hb H disease in California. Genet Test 2001;5:93-100.
3. Forget BG. Molecular mechanisms of β thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin genetics, pathophysiology, and clinical management. Cambridge: Cambridge University Press; 2001. p 252-276.
4. Steinberg MH. Compound heterozygous and other hemoglobinopathies. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. Cambridge: Cambridge University Press; 2001. p 786-810.
5. Sozen M, Karaaslan C, Oner R, et al. Severe hemolytic anemia associated with Hb Volga [β27(B9)Ala→Asp]: GCC→GAC at codon 27 in a Turkish family. Am J Hematol 2004;76:378-382.
6. Wang WC, Carter H, Choitz HC, et al. Characterization of Hb Volga [β 27(B9)Ala→Asp] and Hb J-Wenchang-Wuming [α 11(A9)Lys→Gln] in the population of the United States. Hemoglobin 1993;17:67-71.
7. Luo HY, Adewoye AH, Eung SH, et al. A novel sickle hemoglobin: hemoglobin S-South end. J Pediatr Hematol Oncol 2004;26:773-776.
8. Gγ globin production. Blood 1985;66:783-787.
9. Orkin SH, Goff SC, Hechtman RL. Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci USA 1981;78:5041-5045.
10. Higgs DR, Goodbourn SE, Lamb J, et al. α-Thalassaemia caused by a polyadenylation signal mutation. Nature 1983;306:398-400.
11. Higgs DR. Molecular mechanisms of α thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin genetics, pathophysiology, and clinical management. Cambridge: Cambridge University Press; 2001. p 405-430.
12. Ockelford PA, Liang AY, Wells RM, et al. Hemoglobin Volga, β27 (B9) Ala replaced by Asp: functional and clinical correlations of an unstable hemoglobin. Hemoglobin 1980;4:295-306.
13. Lafferty JD, McFarlane AG, Chui DHK. Evaluation of a dual hemoglobin A(2)/A(1c) quantitation kit on the bio-rad variant II automated hemoglobin analyzer. Arch Pathol Lab Med 2002;126:1494-1500.
14. Higgs DR. Bowden DK. Clinical and laboratory features of the α-thalassemia syndromes. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin; genetics pathophysiology, and clinical management. Cambridge [UK]: Cambridge University Press: 2001. p 431-469.
15. Miller BA, Olivieri N, Salameh M, et al. Molecular analysis of the high hemoglobin F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med 1987;316:244-250.
16. Gale RE, Blair NE, Huehns ER, Clegg JB. Hb A-like sickle haemoglobin: Hb S-Providence. Br J Haematol 1988;70:251-252.
17. Witkowska HE, Lubin BH, Beuzard Y, et al. Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori. N Engl J Med 1991;325:1150-1154.
18. Ma SK, Chow EYD, Chan AYY, et al. β-Thalassemia intermedia caused by compound heterozygosity for Hb Malay (β codon 19 AAC→AGC; Asn→Ser) and codons 41/42 (-CTTT) β°-thalassemia mutation. Am J Hematol 2000;64:206-209.
19. Kuis-Reerink JD, Jonxis JH, Niazi GA, et al. Hb-Volga or α2 β2 27(B9)Ala replaced by Asp. An unstable hemoglobin variant in three generations of a Dutch family. Biochim Biophys Acta 1976;439:63-69.
20. Didkovskii NA, Idel'son LI, Filippova AV, Kasei R, Kinokh P. [Hemoglobin Volga β27 (B9) alanine substituted for aspartic acid (new anomalous hemoglobin with expressed instability)]. Probl Gematol Pereliv Krovi 1977;22:30-34.
21. Sciarratta GV, Ivaldi G, Sansone G, et al. Hb Volga or α2 β2 27(B9)Ala→Asp in an Italian family. Hemoglobin 1985;9:91-93.
22. Blanke S, Johnsen A, Wimberley PD. Hb Volga [β27 (B9) Ala→Asp], a possible de novo mutation in a Danish person. Hemoglobin 1989;13:489-491.
23. Plaseska D, Koceva S, Rasovic N, Efremov GD. Hb Volga [β 27(B9)Ala→Asp]: detection of a de novo mutation by Ava II digestion of PCR-amplified DNA. Hemoglobin 1993;17:209-215.
24. Falcioni G, Grelloni F, Bertoli E, Felici L, Coppa GV. Influence of splenectomy on the properties of erythrocytes with hemoglobin Volga disease. Clin Chim Acta 1991;196:153-158.
25. 2: origin, evolution, and aftermath. Blood 1991;78:2165-2177.
26. Hardison RC, Chui DHK, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 2002;19:225-233.